title: Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial.
authors.affiliation: Donald W. Reynolds Cardiovascular Clinical Research Center, 5323 Harry Hines Blvd, Rm HA 9.133, UT Southwestern Medical Center, Dallas, TX 75390-9047, USA. james.delemos@utsouthwestern.edu
authors.forename: James A
authors.initials: JA
authors.lastname: de Lemos
authors.forename: Michael A
authors.initials: MA
authors.lastname: Blazing
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Wiviott
authors.forename: William E
authors.initials: WE
authors.lastname: Brady
authors.forename: Harvey D
authors.initials: HD
authors.lastname: White
authors.forename: Keith A A
authors.initials: KA
authors.lastname: Fox
authors.forename: Joanne
authors.initials: J
authors.lastname: Palmisano
authors.forename: Karen E
authors.initials: KE
authors.lastname: Ramsey
authors.forename: David W
authors.initials: DW
authors.lastname: Bilheimer
authors.forename: Eldrin F
authors.initials: EF
authors.lastname: Lewis
authors.forename: M
authors.initials: M
authors.lastname: Pfeffer
authors.forename: Robert M
authors.initials: RM
authors.lastname: Califf
authors.forename: Eugene
authors.initials: E
authors.lastname: Braunwald
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D017984:Enoxaparin / Q000627:therapeutic use*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D017984:Enoxaparin; D005343:Fibrinolytic Agents; D014443:Tyrosine; D006493:Heparin; D000077466:Tirofiban; D001241:Aspirin